Sunvozertinib US FDA Label
- Compound: N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide
- Description: Sunvozertinib is an irreversible and selective epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.
- Brand Name:
- Code(s): DZD9008
- Approved:
- Kinase Class: RY
- Inhibitor Type: VI
- Literature (PubMed): 0
- Target(s): epidermal growth factor receptor
- Disease(s): non-small-cell lung carcinoma